Latest On Sangamo Therapeutics, Inc (SGMO):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-22 12:30 EST | News | Sangamo nabs Fast Track designation for Fabry disease candidate | N/A |  |
| 2023-05-17 21:55 EST | News | Pioneering and Delivering the Future of Genomic Medicines | N/A | |
| 2023-05-16 18:45 EST | News | Sangamo Therapeutics appoints Lisa Rojkjaer as CMO | N/A | |
| 2023-04-28 11:03 EST | News | Sangamo downgraded to underperform at BofA on restructuring | N/A | |
| 2023-04-27 22:59 EST | News | Sangamo Therapeutics, Inc. (SGMO) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-04-27 09:54 EST | News | Sangamo Therapeutics, Inc. 2023 Q1 - Results - Earnings Call Presentation | N/A | |
| 2023-04-26 21:54 EST | News | Sangamo Therapeutics to undergo restructuring; laying off 27% of workforce | N/A | |
| 2023-04-25 21:36 EST | News | Sangamo Therapeutics Q1 2023 Earnings Preview | N/A | |
| 2023-04-14 02:34 EST | News | Gene editing stocks rally as Wall Street turns bullish | N/A | |
| 2023-03-23 07:55 EST | News | Sangamo: Hemophilia A Program With Pfizer Key To Success | N/A | |
| 2023-03-18 05:15 EST | News | Sangamo down post-market as Novartis, Biogen end collaborations | N/A | |
| 2023-03-11 04:15 EST | News | Sangamo, Protagonist, and Eiger among biotechs with exposure to Silicon Valley Bank | N/A | |
| 2023-03-02 21:43 EST | News | Sangamo Therapeutics decides not to proceed with public offering | N/A | |
| 2023-02-27 19:38 EST | News | Sangamo gains 11% as Wedbush upgrades on Fabry disease candidate | N/A | |
| 2023-02-24 08:33 EST | News | Sangamo Therapeutics rises 5% on Q4 2022 earnings beats | N/A | |
| 2023-02-23 06:09 EST | News | Sangamo Therapeutics Q4 2022 Earnings Preview | N/A | |
| 2023-02-23 06:09 EST | News | Sangamo Therapeutics, Inc. (SGMO) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-22 17:33 EST | News | Sangamo Therapeutics GAAP EPS of -$0.32 beats by $0.04, revenue of $27.23M beats by $0.37M | N/A | |
| 2023-02-04 01:36 EST | News | Sangamo: Still Not Convincing Enough | N/A | |
| 2022-11-20 05:03 EST | News | Sangamo Therapeutics: Ready To Dust Off My Dormant Position Ahead Of A Pivotal 2023 | N/A | |
| 2022-11-04 08:17 EST | News | Sangamo Therapeutics GAAP EPS of -$0.34 beats by $0.02, revenue of $26.5M misses by $0.29M | N/A | |
| 2022-11-04 08:16 EST | News | Sangamo Therapeutics, Inc. (SGMO) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-02 23:03 EST | News | Sangamo Therapeutics Q3 2022 Earnings Preview | N/A | |
| 2022-09-22 23:22 EST | News | Pfizer, Sangamo reopen recruitment for late-stage trial of hemophilia A gene therapy | N/A | |
| 2022-08-31 18:56 EST | News | Sangamo Therapeutics: Strong Fabry Data Puts Them In The Lead | N/A | |
| 2022-08-30 09:53 EST | News | Sangamo gene therapy for Fabry disease shows promise in phase 1/2 trial | N/A | |
| 2022-08-10 05:34 EST | News | Sangamo Therapeutics: Cheap, But Justifiably So | N/A | |
| 2022-08-05 07:46 EST | News | Sangamo Therapeutics, Inc. 2022 Q2 - Results - Earnings Call Presentation | N/A | |
| 2022-08-05 07:46 EST | News | Sangamo Therapeutics, Inc. (SGMO) CEO Sandy Macrae on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-04 16:42 EST | News | Sangamo Therapeutics GAAP EPS of -$0.29 beats by $0.06, revenue of $29.38M beats by $4.75M | N/A | |
| 2022-08-04 01:48 EST | News | Sangamo Therapeutics Q2 2022 Earnings Preview | N/A | |
| 2022-07-22 05:23 EST | News | Sangamo's TX200 gets orphan drug tag in EU for use in organ transplant | N/A | |
| 2022-06-14 05:36 EST | News | Sangamo Therapeutics begun at neutral at Wedbush on 'frontrunner' Fabry candidate | N/A | |
| 2022-05-07 07:33 EST | News | Sangamo Therapeutics stock slips despite Q1 revenue beat | N/A | |
| 2022-05-06 07:33 EST | News | Sangamo Therapeutics GAAP EPS of -$0.30 beats by $0.01, revenue of $28.23M beats by $0.94M | N/A | |
| 2022-05-06 07:33 EST | News | Sangamo Therapeutics, Inc. (SGMO) CEO Sandy Macrae on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-06 07:33 EST | News | Sangamo Therapeutics, Inc. 2022 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-05-05 10:05 EST | News | Sangamo Therapeutics Q1 2022 Earnings Preview | N/A | |
| 2022-03-30 07:07 EST | News | Sangamo begins dosing in trial of TX200 for preventing kidney transplant rejection | N/A | |
| 2022-02-25 14:19 EST | News | Sangamo Therapeutics, Inc. (SGMO) CEO Sandy Macrae on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-24 19:05 EST | News | Sangamo Therapeutics: Lost In Transition From Lab To Clinic | N/A | |
| 2022-02-24 19:05 EST | News | Sangamo Therapeutics GAAP EPS of -$0.26 beats by $0.09, revenue of $28M beats by $0.64M | N/A | |
| 2022-02-24 19:05 EST | News | Sangamo Therapeutics, Inc. 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-02-24 19:05 EST | News | Sangamo Therapeutics rises 5% after hours following Q4 earnings | N/A | |
| 2022-02-24 01:49 EST | News | Sangamo Therapeutics Q4 2021 Earnings Preview | N/A | |
| 2022-02-09 00:32 EST | News | Sangamo's gene therapy for Fabry Disease shows safety in interim phase 1/2 trial data | N/A | |
| 2022-01-06 18:06 EST | News | Sanofi terminates collaboration with Sangamo for sickle cell disease program | N/A | |
| 2021-12-13 07:15 EST | News | Pfizer, Sangamo's gene therapy shows potential to benefit patients with hemophilia A | N/A | |
| 2021-12-13 07:15 EST | News | Sangamo's SAR445136 shows tolerability and sustained effects in sickle cell disease | N/A | |
| 2021-12-03 20:35 EST | News | Sangamo Therapeutics: Remaining Bullish Ahead ASH Data In December | N/A | |
About Sangamo Therapeutics, Inc (SGMO):
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used in modifying DNA sequences by adding or knocking out specific genes or genome editing; and ZFP transcription factors proteins used in increasing or decreasing gene expression. It develops SB-525, which is in Phase III AFFINE clinical trial for the treatment of hemophilia A; ST-920, a gene therapy, which is in Phase I/II STAAR clinical trials for the treatment of Fabry disease; BIVV003, a cell therapy, which is in Phase I/II PRECIZN-1 clinical trials for the treatment of sickle cell disease; ST-400, a cell therapy, which is in Phase I/II Thales clinical trials for the treatment of transfusion dependent beta thalassemia. The company also develops TX200, chimeric antigen receptor for the treatment of HLA-A2 mismatched kidney transplant rejection; KITE-037, an anti-CD19 CAR-T cell therapy for the treatment of cancer. ST-101 gene therapy for phenylketonuria. It has collaborative and strategic partnerships with Biogen MA, Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi Genzyme; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; Open Monoclonal Technology, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and California Institute for Regenerative Medicine. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was founded in 1995 and is headquartered in Brisbane, California.
General
- Name Sangamo Therapeutics, Inc
- Symbol SGMO
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 413
- Fiscal Year EndDecember
- IPO Date2000-04-06
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.sangamo.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 13.24
- Price/Book (Most Recent Quarter) 3.35
- Enterprise Value Revenue 9.04
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.25
- Next Year EPS Estimate -$1.30
- Next Quarter EPS Estimate -$0.30
- Profit Margin -102%
- Operating Margin -110%
- Return on Assets -10%
- Return on Equity -26%
- Revenue 118.19 million
- Earnings Per Share -$0.99
- Revenue Per Share $0.88
- Gross Profit -62455000
- Quarterly Earnings Growth -53%
View More
Highlights
- Market Capitalization 1.77 billion
- EBITDA -109579000
- PE Ratio -0.34
- Analyst Target Price $19.9
- Book Value Per Share $3.51
View More
Share Statistics
- Shares Outstanding 143.25 million
- Shares Float 118.5 million
- % Held by Insiders 1760%
- % Held by Institutions 58.44%
- Shares Short 15.62 million
- Shares Short Prior Month 15.56 million
- Short Ratio 9.65
- Short % of Float 11%
- Short % of Shares Outstanding 11%
View More
Technicals
- Beta 1.8
- 52 Week High $19.43
- 52 Week Low $5.71
- 50 Day Moving Average 12.79
- 200 Day Moving Average 12.22
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Sangamo Therapeutics, Inc (SGMO) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Sangamo Therapeutics, Inc (SGMO) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-24 | $25.8 million | -$0.29 | -$0.21 | -39.76% |
| 2020-09-30 | 2020-11-04 | $57.76 million | -$0.01 | -$0.25 | 96.08% |
| 2020-06-30 | 2020-08-05 | $N/A | -$0.26 | $0.11 | -338.97% |
| 2020-03-31 | 2020-05-11 | $13.08 million | -$0.37 | -$0.32 | -16.35% |
| 2019-12-31 | 2020-02-28 | $54.85 million | $0.04 | -$0.34 | 111.93% |
| 2019-09-30 | 2019-11-06 | $21.96 million | -$0.24 | -$0.35 | 31.19% |
| 2019-06-30 | 2019-08-07 | $17.55 million | -$0.26 | -$0.34 | 22.39% |
| 2019-03-31 | 2019-05-08 | $8.07 million | -$0.41 | -$0.26 | -60.16% |
| 2018-12-31 | 2019-02-28 | $26.84 million | -$0.18 | -$0.22 | 19.54% |
| 2018-09-30 | 2018-11-08 | $23.56 million | -$0.13 | -$0.17 | 24.42% |
| 2018-06-30 | 2018-08-08 | $21.42 million | -$0.17 | -$0.15 | -14.86% |
| 2018-03-31 | 2018-05-08 | $12.64 million | -$0.23 | -$0.15 | -56.78% |
| 2017-12-31 | 2018-02-22 | $13.08 million | -$0.15 | -$0.18 | 15.73% |
| 2017-09-30 | 2017-11-09 | $11.81 million | -$0.15 | -$0.19 | 21.88% |
| 2017-06-30 | 2017-08-09 | $8.25 million | -$0.17 | -$0.24 | 28.15% |
| 2017-03-31 | 2017-05-10 | $3.43 million | -$0.23 | -$0.26 | 10.26% |
| 2016-12-31 | 2017-02-28 | $8.92 million | -$0.14 | -$0.26 | 45.12% |
| 2016-09-30 | 2016-10-26 | $2.82 million | -$0.27 | -$0.25 | -8.91% |
| 2016-06-30 | 2016-08-03 | $3.7 million | -$0.38 | -$0.24 | -59.26% |
| 2016-03-31 | 2016-05-02 | $3.94 million | -$0.23 | -$0.25 | 6.92% |
| 2015-12-31 | 2016-02-09 | $9.12 million | -$0.20 | -$0.21 | 4.9% |
| 2015-09-30 | 2015-10-28 | $8.57 million | -$0.13 | -$0.24 | 45.83% |
| 2015-06-30 | 2015-08-05 | $8.36 million | -$0.17 | -$0.12 | -41.67% |
| 2015-03-31 | 2015-04-22 | $13.49 million | -$0.08 | -$0.14 | 42.86% |
| 2014-12-31 | 2015-02-10 | $14.95 million | -$0.06 | -$0.09 | 33.33% |
| 2014-09-30 | 2014-10-22 | $12.42 million | -$0.11 | -$0.14 | 21.43% |
| 2014-06-30 | 2014-07-23 | $10.39 million | -$0.10 | -$0.13 | 23.08% |
| 2014-03-31 | 2014-05-06 | $8.12 million | -$0.12 | -$0.12 | 0% |
| 2013-12-31 | 2014-02-11 | $6.87 million | -$0.13 | -$0.10 | -30% |
| 2013-09-30 | 2013-10-23 | $5.71 million | -$0.11 | -$0.11 | 0% |
| 2013-06-30 | 2013-07-24 | $6.93 million | -$0.10 | -$0.13 | 23.08% |
| 2013-03-31 | 2013-05-08 | $4.62 million | -$0.13 | -$0.16 | 18.75% |
| 2012-12-31 | 2013-02-06 | $8.93 million | -$0.07 | -$0.12 | 41.67% |
| 2012-09-30 | 2012-10-24 | $4.91 million | -$0.11 | -$0.13 | 15.38% |
| 2012-06-30 | 2012-07-25 | $4.57 million | -$0.11 | -$0.14 | 21.43% |
| 2012-03-31 | 2012-05-02 | $3.24 million | -$0.14 | -$0.15 | 6.67% |
| 2011-12-31 | 2012-02-08 | $4.75 million | -$0.12 | -$0.12 | 0% |
| 2011-09-30 | 2011-10-25 | $1.86 million | -$0.18 | -$0.16 | -12.5% |
| 2011-06-30 | 2011-07-27 | $1.51 million | -$0.20 | -$0.16 | -25% |
| 2011-03-31 | 2011-04-26 | $2.2 million | -$0.21 | -$0.17 | -23.53% |
| 2010-12-31 | 2011-02-02 | $4.69 million | -$0.18 | -$0.19 | 5.26% |
| 2010-09-30 | 2010-10-27 | $2.94 million | -$0.19 | -$0.15 | -26.67% |
| 2010-06-30 | 2010-07-28 | $6.53 million | -$0.09 | -$0.08 | -12.5% |
| 2010-03-31 | 2010-05-03 | $6.65 million | -$0.09 | ||
| 2009-12-31 | 2010-02-03 | $10.24 million | -$0.05 | -$0.07 | 28.57% |
| 2009-09-30 | 2009-11-04 | $4.06 million | -$0.12 | -$0.13 | 7.69% |
| 2009-06-30 | 2009-07-29 | $4.73 million | -$0.11 | -$0.15 | 26.67% |
| 2009-03-31 | 2009-04-29 | $3.16 million | -$0.17 | -$0.10 | -70% |
| 2008-12-31 | 2009-02-04 | $6.83 million | -$0.06 | -$0.14 | 57.14% |
| 2008-09-30 | 2008-10-29 | $3.75 million | -$0.15 | -$0.16 | 6.25% |
| 2008-06-30 | 2008-07-23 | $2.84 million | -$0.18 | -$0.18 | 0% |
| 2008-03-31 | 2008-04-30 | $2.77 million | -$0.20 | -$0.16 | -25% |
| 2007-12-31 | 2008-02-05 | $2.77 million | -$0.17 | -$0.13 | -30.77% |
| 2007-09-30 | 2007-10-24 | $2.33 million | -$0.11 | -$0.14 | 21.43% |
| 2007-06-30 | 2007-07-24 | $2.58 million | -$0.15 | -$0.14 | -7.14% |
| 2007-03-31 | 2007-05-01 | $1.42 million | -$0.15 | -$0.13 | -15.38% |
| 2006-12-31 | 2007-02-08 | $2.19 million | -$0.26 | -$0.08 | -225% |
| 2006-09-30 | 2006-10-30 | $1.78 million | -$0.09 | -$0.13 | 30.77% |
| 2006-06-30 | 2006-07-25 | $1.78 million | -$0.11 | -$0.11 | 0% |
| 2006-03-31 | 2006-05-01 | $2.14 million | -$0.09 | -$0.11 | 18.18% |
| 2005-12-31 | 2006-02-09 | $1.4 million | -$0.10 | -$0.11 | 9.09% |
| 2005-09-30 | 2005-10-27 | $413000 | -$0.14 | -$0.14 | 0% |
| 2005-06-30 | 2005-07-19 | $418000 | -$0.13 | -$0.15 | 13.33% |
| 2005-03-31 | 2005-04-28 | $256000 | -$0.14 | -$0.14 | 0% |
| 2004-12-31 | 2005-02-16 | $200000 | -$0.12 | -$0.17 | 29.41% |
| 2004-09-30 | 2004-11-03 | $172000 | -$0.18 | -$0.14 | -28.57% |
| 2004-06-30 | 2004-07-21 | $132000 | -$0.13 | -$0.13 | 0% |
| 2004-03-31 | 2004-04-29 | $811000 | -$0.12 | -$0.10 | -20% |
| 2003-12-31 | 2004-02-11 | $1 million | -$0.06 | -$0.11 | 45.45% |
| 2003-09-30 | 2003-10-28 | $507000 | -$0.10 | -$0.13 | 23.08% |
| 2003-06-30 | 2003-07-28 | $518000 | -$0.13 | -$0.10 | -30% |
| 2003-03-31 | 2003-04-29 | $551000 | -$0.11 | -$0.10 | -10% |
| 2002-12-31 | 2003-02-05 | $2.46 million | -$0.02 | -$0.08 | 75% |
| 2002-09-30 | 2002-10-30 | $1.01 million | -$0.10 | -$0.09 | -11.11% |
| 2002-06-30 | 2002-07-24 | $366000 | -$0.14 | -$0.12 | -16.67% |
| 2002-03-31 | 2002-04-25 | $501000 | -$0.13 | -$0.12 | -8.33% |
| 2001-12-31 | 2002-02-05 | $2.16 million | -$0.08 | -$0.07 | -14.29% |
| 2001-09-30 | 2001-10-18 | $739000 | -$0.14 | -$0.09 | -55.56% |
| 2001-06-30 | 2001-07-19 | $1.35 million | -$0.08 | -$0.10 | 20% |
| 2001-03-31 | 2001-04-25 | $634000 | -$0.06 | -$0.08 | 25% |
| 2000-12-31 | 2001-02-01 | $1.06 million | -$0.05 | -$0.07 | 28.57% |
| 2000-09-30 | 2000-10-10 | $823000 | -$0.03 | -$0.03 | 0% |
| 2000-06-30 | 2000-08-09 | $747000 | -$0.03 | -$0.05 | 40% |
Sangamo Therapeutics, Inc (SGMO) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Sangamo Therapeutics, Inc (SGMO) Chart:
Sangamo Therapeutics, Inc (SGMO) News:
Below you will find a list of latest news for Sangamo Therapeutics, Inc (SGMO) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Sangamo Therapeutics, Inc (SGMO) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 0.5 | 0.07 | CALL | 13 | 239 | 141.32 | FALSE | -0.06 | -0.46 |
| 2024-05-17 | 1 | 0.02 | CALL | 9 | 2694 | 208.73 | FALSE | 0.01 | 1 |
| 2024-05-17 | 1.5 | 0.11 | CALL | 0 | 182 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2 | 0.05 | CALL | 0 | 802 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 3 | 0.05 | CALL | 0 | 248 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 4 | 0.05 | CALL | 0 | 111 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 0.5 | 0.05 | PUT | 0 | 112 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 1 | 0.5 | PUT | 2 | 1148 | 892.07 | TRUE | 0.5 | 0 |
| 2024-05-17 | 1.5 | 0.65 | PUT | 0 | 5 | 1380.92 | TRUE | 0 | 0 |
| 2024-05-17 | 2 | 1.52 | PUT | 0 | 7 | 636.45 | TRUE | 0 | 0 |
| 2024-05-17 | 3 | 0 | PUT | 0 | 0 | 1084.86 | TRUE | 0 | 0 |
| 2024-05-17 | 4 | 0 | PUT | 0 | 0 | 708.88 | TRUE | 0 | 0 |
| 2024-06-21 | 0.5 | 0.15 | CALL | 2 | 0 | 196.14 | FALSE | 0.15 | 0 |
| 2024-06-21 | 1 | 0.1 | CALL | 20 | 0 | 253.18 | FALSE | 0.1 | 0 |
| 2024-06-21 | 1.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 3 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 4 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 0.5 | 0 | PUT | 0 | 0 | 181.96 | TRUE | 0 | 0 |
| 2024-06-21 | 1 | 0 | PUT | 0 | 0 | 210.9 | TRUE | 0 | 0 |
| 2024-06-21 | 1.5 | 0 | PUT | 0 | 0 | 426.6 | TRUE | 0 | 0 |
| 2024-06-21 | 2 | 0 | PUT | 0 | 0 | 464.2 | TRUE | 0 | 0 |
| 2024-06-21 | 3 | 0 | PUT | 0 | 0 | 387.69 | TRUE | 0 | 0 |
| 2024-06-21 | 4 | 0 | PUT | 0 | 0 | 890.88 | TRUE | 0 | 0 |
| 2024-08-16 | 0.5 | 0.15 | CALL | 18 | 182 | 141.37 | FALSE | 0.15 | 0 |
| 2024-08-16 | 1 | 0.12 | CALL | 0 | 1405 | 183.36 | FALSE | 0 | 0 |
| 2024-08-16 | 1.5 | 0.05 | CALL | 1 | 602 | 172.6 | FALSE | 0.05 | 0 |
| 2024-08-16 | 2 | 0.05 | CALL | 0 | 745 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 3 | 0.14 | CALL | 0 | 148 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 4 | 0.05 | CALL | 0 | 103 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 0.5 | 0.1 | PUT | 0 | 287 | 87.27 | TRUE | 0 | 0 |
| 2024-08-16 | 1 | 0.5 | PUT | 0 | 787 | 132.49 | TRUE | 0 | 0 |
| 2024-08-16 | 1.5 | 0.77 | PUT | 0 | 56 | 225.15 | TRUE | 0 | 0 |
| 2024-08-16 | 2 | 1.15 | PUT | 0 | 3 | 201.88 | TRUE | 0 | 0 |
| 2024-08-16 | 3 | 0 | PUT | 0 | 0 | 363.29 | TRUE | 0 | 0 |
| 2024-08-16 | 4 | 0 | PUT | 0 | 0 | 321.41 | TRUE | 0 | 0 |
| 2024-11-15 | 0.5 | 0.2 | CALL | 3 | 82 | 142.88 | FALSE | 0.2 | 0 |
| 2024-11-15 | 1 | 0.15 | CALL | 93 | 379 | 171.16 | FALSE | -0.05 | -0.25 |
| 2024-11-15 | 1.5 | 0.44 | CALL | 0 | 5 | 426.99 | FALSE | 0 | 0 |
| 2024-11-15 | 2 | 0.2 | CALL | 0 | 15 | 442.81 | FALSE | 0 | 0 |
| 2024-11-15 | 3 | 0.05 | CALL | 0 | 110 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 4 | 0.05 | CALL | 0 | 12 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 0.5 | 0.2 | PUT | 0 | 211 | 141.57 | TRUE | 0 | 0 |
| 2024-11-15 | 1 | 0.55 | PUT | 0 | 13 | 141.86 | TRUE | 0 | 0 |
| 2024-11-15 | 1.5 | 0.8 | PUT | 0 | 8 | 158.39 | TRUE | 0 | 0 |
| 2024-11-15 | 2 | 1.47 | PUT | 0 | 0 | 181.69 | TRUE | 0 | 0 |
| 2024-11-15 | 3 | 0 | PUT | 0 | 0 | 214.13 | TRUE | 0 | 0 |
| 2024-11-15 | 4 | 0 | PUT | 0 | 0 | 256.58 | TRUE | 0 | 0 |
Latest SGMO Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 200 | $3.285 |
| Jun 13, 2022 7:59 PM EST | 2000 | $3.29 |
| Jun 13, 2022 7:59 PM EST | 200 | $3.295 |
| Jun 13, 2022 7:59 PM EST | 100 | $3.295 |
| Jun 13, 2022 7:59 PM EST | 2000 | $3.29 |
Sangamo Therapeutics, Inc (SGMO) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120039346/0001209191-20-039346-index.htm |
| 2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001233/000009375119000171/0000093751-19-000171-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001233/000009375120000471/0000093751-20-000471-index.htm |
| 2019-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001233/000021545719005593/0000215457-19-005593-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001233/000031506619001338/0000315066-19-001338-index.htm |
| 2020-02-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001233/000081413320000034/0000814133-20-000034-index.htm |
| 2020-02-06 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001233/000083423720006744/0000834237-20-006744-index.htm |
| 2020-04-22 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000089924320011158/0000899243-20-011158-index.htm |
| 2020-01-28 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001233/000090221920000241/0000902219-20-000241-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001233/000093247119006119/0000932471-19-006119-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001233/000110465920018542/0001104659-20-018542-index.htm |
| 2018-07-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312518223059/0001193125-18-223059-index.htm |
| 2018-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312518242792/0001193125-18-242792-index.htm |
| 2018-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312518289545/0001193125-18-289545-index.htm |
| 2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312518319603/0001193125-18-319603-index.htm |
| 2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312518322617/0001193125-18-322617-index.htm |
| 2019-02-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312519036816/0001193125-19-036816-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312519057486/0001193125-19-057486-index.htm |
| 2019-03-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312519082295/0001193125-19-082295-index.htm |
| 2019-04-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312519096634/0001193125-19-096634-index.htm |
| 2019-04-03 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1001233/000119312519096635/0001193125-19-096635-index.htm |
| 2019-04-04 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1001233/000119312519097984/0001193125-19-097984-index.htm |
| 2019-04-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312519097991/0001193125-19-097991-index.htm |
| 2019-04-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312519109191/0001193125-19-109191-index.htm |
| 2019-04-25 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1001233/000119312519119748/0001193125-19-119748-index.htm |
| 2019-04-25 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1001233/000119312519119758/0001193125-19-119758-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312519141430/0001193125-19-141430-index.htm |
| 2019-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312519146005/0001193125-19-146005-index.htm |
| 2019-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312519173647/0001193125-19-173647-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312519215409/0001193125-19-215409-index.htm |
| 2019-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312519283369/0001193125-19-283369-index.htm |
| 2019-11-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312519301242/0001193125-19-301242-index.htm |
| 2019-12-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312519321791/0001193125-19-321791-index.htm |
| 2020-02-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312520038600/0001193125-20-038600-index.htm |
| 2020-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312520054118/0001193125-20-054118-index.htm |
| 2020-04-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312520110621/0001193125-20-110621-index.htm |
| 2020-04-17 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1001233/000119312520110651/0001193125-20-110651-index.htm |
| 2020-05-08 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1001233/000119312520136576/0001193125-20-136576-index.htm |
| 2020-05-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312520150198/0001193125-20-150198-index.htm |
| 2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312520171977/0001193125-20-171977-index.htm |
| 2020-06-18 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312520172284/0001193125-20-172284-index.htm |
| 2020-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000119312520177699/0001193125-20-177699-index.htm |
| 2020-08-05 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1001233/000119312520210798/0001193125-20-210798-index.htm |
| 2020-08-06 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1001233/000119312520210940/0001193125-20-210940-index.htm |
| 2020-10-15 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1001233/000119312520269552/0001193125-20-269552-index.htm |
| 2018-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919118042845/0001209191-18-042845-index.htm |
| 2018-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919118045758/0001209191-18-045758-index.htm |
| 2018-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919118047359/0001209191-18-047359-index.htm |
| 2018-09-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919118050085/0001209191-18-050085-index.htm |
| 2018-09-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919118050123/0001209191-18-050123-index.htm |
| 2018-09-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919118050149/0001209191-18-050149-index.htm |
| 2018-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919118051500/0001209191-18-051500-index.htm |
| 2018-10-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919118054196/0001209191-18-054196-index.htm |
| 2018-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919118054573/0001209191-18-054573-index.htm |
| 2018-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919118055200/0001209191-18-055200-index.htm |
| 2018-11-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919118057677/0001209191-18-057677-index.htm |
| 2018-11-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919118058823/0001209191-18-058823-index.htm |
| 2018-11-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919118059015/0001209191-18-059015-index.htm |
| 2018-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919118059976/0001209191-18-059976-index.htm |
| 2018-12-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919118061668/0001209191-18-061668-index.htm |
| 2018-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919118063265/0001209191-18-063265-index.htm |
| 2019-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119002871/0001209191-19-002871-index.htm |
| 2019-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119003926/0001209191-19-003926-index.htm |
| 2019-01-23 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119005052/0001209191-19-005052-index.htm |
| 2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119005618/0001209191-19-005618-index.htm |
| 2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119005619/0001209191-19-005619-index.htm |
| 2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119005621/0001209191-19-005621-index.htm |
| 2019-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119014296/0001209191-19-014296-index.htm |
| 2019-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119014297/0001209191-19-014297-index.htm |
| 2019-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119014300/0001209191-19-014300-index.htm |
| 2019-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119014302/0001209191-19-014302-index.htm |
| 2019-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119014304/0001209191-19-014304-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119017164/0001209191-19-017164-index.htm |
| 2019-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119020126/0001209191-19-020126-index.htm |
| 2019-04-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119024836/0001209191-19-024836-index.htm |
| 2019-04-18 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119025290/0001209191-19-025290-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119031065/0001209191-19-031065-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119036434/0001209191-19-036434-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119036440/0001209191-19-036440-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119036441/0001209191-19-036441-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119036442/0001209191-19-036442-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119036443/0001209191-19-036443-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119036449/0001209191-19-036449-index.htm |
| 2019-06-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119037747/0001209191-19-037747-index.htm |
| 2019-08-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119044777/0001209191-19-044777-index.htm |
| 2019-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119045960/0001209191-19-045960-index.htm |
| 2019-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119045963/0001209191-19-045963-index.htm |
| 2019-09-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119050911/0001209191-19-050911-index.htm |
| 2019-11-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119055294/0001209191-19-055294-index.htm |
| 2019-11-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119058096/0001209191-19-058096-index.htm |
| 2019-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119058100/0001209191-19-058100-index.htm |
| 2019-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919119058104/0001209191-19-058104-index.htm |
| 2020-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120005247/0001209191-20-005247-index.htm |
| 2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120006107/0001209191-20-006107-index.htm |
| 2020-02-12 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120008969/0001209191-20-008969-index.htm |
| 2020-02-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120009452/0001209191-20-009452-index.htm |
| 2020-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120009453/0001209191-20-009453-index.htm |
| 2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120013228/0001209191-20-013228-index.htm |
| 2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120013229/0001209191-20-013229-index.htm |
| 2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120013230/0001209191-20-013230-index.htm |
| 2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120013231/0001209191-20-013231-index.htm |
| 2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120013232/0001209191-20-013232-index.htm |
| 2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120013233/0001209191-20-013233-index.htm |
| 2020-02-26 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120013239/0001209191-20-013239-index.htm |
| 2020-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120013311/0001209191-20-013311-index.htm |
| 2020-02-27 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120013315/0001209191-20-013315-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120019005/0001209191-20-019005-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120020143/0001209191-20-020143-index.htm |
| 2020-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120020303/0001209191-20-020303-index.htm |
| 2020-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120020353/0001209191-20-020353-index.htm |
| 2020-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120020483/0001209191-20-020483-index.htm |
| 2020-03-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120021346/0001209191-20-021346-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120026045/0001209191-20-026045-index.htm |
| 2020-05-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120027773/0001209191-20-027773-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120030947/0001209191-20-030947-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120030948/0001209191-20-030948-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120030956/0001209191-20-030956-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120030959/0001209191-20-030959-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120030961/0001209191-20-030961-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120030965/0001209191-20-030965-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120030966/0001209191-20-030966-index.htm |
| 2020-06-03 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120034013/0001209191-20-034013-index.htm |
| 2020-06-03 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120034015/0001209191-20-034015-index.htm |
| 2020-06-03 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120034020/0001209191-20-034020-index.htm |
| 2020-06-03 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120034022/0001209191-20-034022-index.htm |
| 2020-06-03 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120034026/0001209191-20-034026-index.htm |
| 2020-06-03 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120034029/0001209191-20-034029-index.htm |
| 2020-06-03 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120034033/0001209191-20-034033-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120034882/0001209191-20-034882-index.htm |
| 2020-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120039346/0001209191-20-039346-index.htm |
| 2020-07-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120044347/0001209191-20-044347-index.htm |
| 2020-09-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120050207/0001209191-20-050207-index.htm |
| 2020-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1001233/000120919120050208/0001209191-20-050208-index.htm |
| 2018-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1001233/000156459018020536/0001564590-18-020536-index.htm |
| 2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1001233/000156459018028636/0001564590-18-028636-index.htm |
| 2019-01-07 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000156459019000230/0001564590-19-000230-index.htm |
| 2019-03-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1001233/000156459019005808/0001564590-19-005808-index.htm |
| 2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1001233/000156459019017255/0001564590-19-017255-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1001233/000162828019010300/0001628280-19-010300-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000162828019013502/0001628280-19-013502-index.htm |
| 2019-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1001233/000162828019013510/0001628280-19-013510-index.htm |
| 2020-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1001233/000162828020002582/0001628280-20-002582-index.htm |
| 2020-03-23 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1001233/000162828020003951/0001628280-20-003951-index.htm |
| 2020-04-02 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1001233/000162828020004486/0001628280-20-004486-index.htm |
| 2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000162828020007431/0001628280-20-007431-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1001233/000162828020007462/0001628280-20-007462-index.htm |
| 2020-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000162828020011013/0001628280-20-011013-index.htm |
| 2020-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000162828020011019/0001628280-20-011019-index.htm |
| 2020-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000162828020011027/0001628280-20-011027-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000162828020011796/0001628280-20-011796-index.htm |
| 2020-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1001233/000162828020011806/0001628280-20-011806-index.htm |
| 2020-09-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000162828020013516/0001628280-20-013516-index.htm |
| 2020-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1001233/000162828020015492/0001628280-20-015492-index.htm |
| 2020-11-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1001233/000162828020015504/0001628280-20-015504-index.htm |
| 2018-12-03 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1001233/999999999718009241/9999999997-18-009241-index.htm |
| 2019-02-26 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1001233/999999999719000585/9999999997-19-000585-index.htm |
| 2019-02-26 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1001233/999999999719000586/9999999997-19-000586-index.htm |
| 2019-02-26 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1001233/999999999719000590/9999999997-19-000590-index.htm |
| 2020-02-03 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1001233/999999999720000414/9999999997-20-000414-index.htm |
Sangamo Therapeutics, Inc (SGMO) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sangamo Therapeutics, Inc (SGMO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1760%Institutional Ownership: 5844%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-06-10 | H STEWART PARKER | Director | Buy | 2,500.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119036441/0001209191-19-036441-index.htm | ||
| 2020-05-18 | Karen L. Smith | Director | Buy | 2,500.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120030965/0001209191-20-030965-index.htm | ||
| 2020-06-25 | David Mark McClung | EVP, Chief Business Officer | Buy | 100,000.00 | 100,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120039346/0001209191-20-039346-index.htm | ||
| 2018-08-06 | Edward R. Conner | Sr. VP & Chief Medical Officer | Sell | 5,000.00 | 13.45 | 67,250.00 | 10,125.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118045758/0001209191-18-045758-index.htm |
| 2018-09-06 | Edward R. Conner | Sr. VP & Chief Medical Officer | Sell | 5,000.00 | 14.17 | 70,845.00 | 10,125.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118050085/0001209191-18-050085-index.htm |
| 2018-10-08 | Edward R. Conner | Sr. VP & Chief Medical Officer | Sell | 5,000.00 | 14.55 | 72,773.50 | 10,125.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118054573/0001209191-18-054573-index.htm |
| 2018-11-06 | Edward R. Conner | Sr. VP & Chief Medical Officer | Sell | 5,000.00 | 13.73 | 68,650.00 | 12,125.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118057677/0001209191-18-057677-index.htm |
| 2018-12-06 | Edward R. Conner | Sr. VP & Chief Medical Officer | Sell | 5,000.00 | 11.49 | 57,433.00 | 12,125.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118061668/0001209191-18-061668-index.htm |
| 2019-01-07 | Edward R. Conner | Sr. VP & Chief Medical Officer | Sell | 5,000.00 | 12.33 | 61,630.50 | 12,125.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119002871/0001209191-19-002871-index.htm |
| 2018-07-16 | Kathy Yi | SVP & Chief Financial Officer | Buy | 5,000.00 | 4.55 | 22,750.00 | 12,250.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118042845/0001209191-18-042845-index.htm |
| 2018-08-16 | Kathy Yi | SVP & Chief Financial Officer | Buy | 5,000.00 | 4.55 | 22,750.00 | 12,250.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118047359/0001209191-18-047359-index.htm |
| 2018-09-17 | Kathy Yi | SVP & Chief Financial Officer | Buy | 5,000.00 | 4.55 | 22,750.00 | 12,250.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118051500/0001209191-18-051500-index.htm |
| 2018-10-15 | Kathy Yi | SVP & Chief Financial Officer | Buy | 5,000.00 | 4.55 | 22,750.00 | 12,250.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118055200/0001209191-18-055200-index.htm |
| 2018-11-15 | Kathy Yi | SVP & Chief Financial Officer | Buy | 5,000.00 | 4.55 | 22,750.00 | 12,250.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118059015/0001209191-18-059015-index.htm |
| 2018-12-17 | Kathy Yi | SVP & Chief Financial Officer | Buy | 5,000.00 | 4.55 | 22,750.00 | 12,250.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118063265/0001209191-18-063265-index.htm |
| 2019-01-15 | Kathy Yi | SVP & Chief Financial Officer | Buy | 5,000.00 | 4.55 | 22,750.00 | 12,250.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119003926/0001209191-19-003926-index.htm |
| 2020-03-18 | H STEWART PARKER | Director | Buy | 3,000.00 | 5.20 | 15,585.00 | 13,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120020353/0001209191-20-020353-index.htm |
| 2020-09-09 | Kenneth J. Hillan | Director | Buy | 15,000.00 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120050208/0001209191-20-050208-index.htm | ||
| 2018-08-06 | Edward R. Conner | Sr. VP & Chief Medical Officer | Buy | 5,000.00 | 3.20 | 16,000.00 | 15,125.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118045758/0001209191-18-045758-index.htm |
| 2018-09-06 | Edward R. Conner | Sr. VP & Chief Medical Officer | Buy | 5,000.00 | 3.20 | 16,000.00 | 15,125.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118050085/0001209191-18-050085-index.htm |
| 2018-10-08 | Edward R. Conner | Sr. VP & Chief Medical Officer | Buy | 5,000.00 | 3.20 | 16,000.00 | 15,125.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118054573/0001209191-18-054573-index.htm |
| 2020-05-18 | H STEWART PARKER | Director | Buy | 2,500.00 | 15,500.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120030959/0001209191-20-030959-index.htm | ||
| 2018-11-06 | Edward R. Conner | Sr. VP & Chief Medical Officer | Buy | 5,000.00 | 3.20 | 16,000.00 | 17,125.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118057677/0001209191-18-057677-index.htm |
| 2018-12-06 | Edward R. Conner | Sr. VP & Chief Medical Officer | Buy | 5,000.00 | 3.20 | 16,000.00 | 17,125.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118061668/0001209191-18-061668-index.htm |
| 2019-01-07 | Edward R. Conner | Sr. VP & Chief Medical Officer | Buy | 5,000.00 | 3.20 | 16,000.00 | 17,125.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119002871/0001209191-19-002871-index.htm |
| 2019-02-25 | Stephane Boissel | EVP, Corporate Strategy | Buy | 17,500.00 | 17,500.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119014302/0001209191-19-014302-index.htm | ||
| 2019-08-12 | Stephane Boissel | EVP, Corp. Strat. & Int. CFO | Sell | 11,137.00 | 11.23 | 125,068.51 | 17,500.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119045963/0001209191-19-045963-index.htm |
| 2019-02-25 | Heather D Turner | EVP, General Counsel & Sec. | Buy | 19,250.00 | 19,250.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119014300/0001209191-19-014300-index.htm | ||
| 2020-03-12 | Joseph S Zakrzewski | Director | Buy | 15,000.00 | 6.31 | 94,650.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120019005/0001209191-20-019005-index.htm |
| 2020-03-16 | STEPHEN GEORGE DILLY | Director | Buy | 15,000.00 | 5.42 | 81,300.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120020143/0001209191-20-020143-index.htm |
| 2020-02-25 | Prathyusha Duraibabu | VP Principal Acct. Officer | Buy | 16,500.00 | 22,250.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120013233/0001209191-20-013233-index.htm | ||
| 2020-02-25 | Sandy Macrae | President and CEO | Buy | 168,750.00 | 247,979.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120013228/0001209191-20-013228-index.htm | ||
| 2020-03-13 | Joseph S Zakrzewski | Director | Buy | 5,000.00 | 5.67 | 28,350.00 | 25,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120019005/0001209191-20-019005-index.htm |
| 2019-02-25 | Kathy Yi | EVP & Chief Financial Officer | Buy | 19,250.00 | 25,512.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119014297/0001209191-19-014297-index.htm | ||
| 2019-03-01 | Kathy Yi | EVP & Chief Financial Officer | Sell | 5,000.00 | 10.00 | 50,000.00 | 25,512.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119017164/0001209191-19-017164-index.htm |
| 2019-03-15 | Kathy Yi | EVP & Chief Financial Officer | Sell | 5,000.00 | 10.00 | 50,000.00 | 25,512.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119020126/0001209191-19-020126-index.htm |
| 2019-04-15 | Kathy Yi | EVP & Chief Financial Officer | Sell | 5,000.00 | 12.11 | 60,550.00 | 25,512.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119024836/0001209191-19-024836-index.htm |
| 2019-05-15 | Kathy Yi | EVP & Chief Financial Officer | Sell | 5,000.00 | 10.00 | 50,000.00 | 25,512.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119031065/0001209191-19-031065-index.htm |
| 2020-03-25 | Prathyusha Duraibabu | VP Principal Acct. Officer | Buy | 3,000.00 | 27,250.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120021346/0001209191-20-021346-index.htm | ||
| 2019-08-12 | Stephane Boissel | EVP, Corp. Strat. & Int. CFO | Buy | 11,137.00 | 28,637.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119045963/0001209191-19-045963-index.htm | ||
| 2020-03-17 | Joseph S Zakrzewski | Director | Buy | 5,000.00 | 4.99 | 24,950.00 | 30,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120020303/0001209191-20-020303-index.htm |
| 2019-03-01 | Kathy Yi | EVP & Chief Financial Officer | Buy | 5,000.00 | 4.55 | 22,750.00 | 30,512.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119017164/0001209191-19-017164-index.htm |
| 2019-03-15 | Kathy Yi | EVP & Chief Financial Officer | Buy | 5,000.00 | 4.55 | 22,750.00 | 30,512.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119020126/0001209191-19-020126-index.htm |
| 2019-04-15 | Kathy Yi | EVP & Chief Financial Officer | Buy | 5,000.00 | 4.55 | 22,750.00 | 30,512.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119024836/0001209191-19-024836-index.htm |
| 2019-05-15 | Kathy Yi | EVP & Chief Financial Officer | Buy | 5,000.00 | 4.55 | 22,750.00 | 30,512.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119031065/0001209191-19-031065-index.htm |
| 2020-05-18 | Joseph S Zakrzewski | Director | Buy | 2,500.00 | 32,500.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120030966/0001209191-20-030966-index.htm | ||
| 2020-03-19 | STEPHEN GEORGE DILLY | Director | Buy | 35,000.00 | 5.42 | 189,700.00 | 40,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120020483/0001209191-20-020483-index.htm |
| 2019-11-25 | Sung Lee | EVP, Chief Financial Officer | Buy | 43,750.00 | 43,750.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119058104/0001209191-19-058104-index.htm | ||
| 2019-11-22 | James R Meyers | Director | Buy | 5,000.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119058100/0001209191-19-058100-index.htm | ||
| 2020-02-11 | John Markels | Director | Buy | 5,000.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120009453/0001209191-20-009453-index.htm | ||
| 2019-06-10 | Joseph S Zakrzewski | Director | Buy | 2,500.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119036449/0001209191-19-036449-index.htm | ||
| 2019-06-10 | Robert Carey | Director | Buy | 2,500.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119036434/0001209191-19-036434-index.htm | ||
| 2019-06-10 | Saira Ramasastry | Director | Buy | 2,500.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119036442/0001209191-19-036442-index.htm | ||
| 2019-06-10 | STEPHEN GEORGE DILLY | Director | Buy | 2,500.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119036440/0001209191-19-036440-index.htm | ||
| 2020-03-16 | STEPHEN GEORGE DILLY | Director | Sell | 15,000.00 | 6.02 | 90,261.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120020143/0001209191-20-020143-index.htm |
| 2020-03-19 | STEPHEN GEORGE DILLY | Director | Sell | 35,000.00 | 6.00 | 210,000.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120020483/0001209191-20-020483-index.htm |
| 2020-02-25 | Adrian Woolfson | EVP Research & Development | Buy | 50,000.00 | 50,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120013311/0001209191-20-013311-index.htm | ||
| 2020-02-25 | GARY LOEB | EVP, General Counsel & Sec. | Buy | 500,000.00 | 50,000.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120013231/0001209191-20-013231-index.htm | ||
| 2018-09-07 | H STEWART PARKER | Director | Buy | 2,000.00 | 13.52 | 27,040.00 | 5,500.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118050123/0001209191-18-050123-index.htm |
| 2020-02-25 | Rolf Andrew Ramelmeier | EVP, Technical Operations | Buy | 55,000.00 | 69,128.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120013232/0001209191-20-013232-index.htm | ||
| 2020-02-25 | Stephane Boissel | EVP, Corp. Strategy | Buy | 55,000.00 | 70,116.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120013229/0001209191-20-013229-index.htm | ||
| 2020-06-04 | Stephane Boissel | EVP, Corp. Strategy | Sell | 14,907.00 | 11.23 | 167,405.61 | 70,116.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120034882/0001209191-20-034882-index.htm |
| 2018-07-16 | Kathy Yi | SVP & Chief Financial Officer | Sell | 5,000.00 | 14.77 | 73,860.00 | 7,250.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118042845/0001209191-18-042845-index.htm |
| 2018-08-16 | Kathy Yi | SVP & Chief Financial Officer | Sell | 5,000.00 | 15.39 | 76,951.50 | 7,250.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118047359/0001209191-18-047359-index.htm |
| 2018-09-17 | Kathy Yi | SVP & Chief Financial Officer | Sell | 5,000.00 | 14.66 | 73,284.50 | 7,250.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118051500/0001209191-18-051500-index.htm |
| 2018-10-15 | Kathy Yi | SVP & Chief Financial Officer | Sell | 5,000.00 | 13.97 | 69,850.00 | 7,250.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118055200/0001209191-18-055200-index.htm |
| 2018-11-15 | Kathy Yi | SVP & Chief Financial Officer | Sell | 5,000.00 | 10.00 | 50,000.00 | 7,250.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118059015/0001209191-18-059015-index.htm |
| 2018-12-17 | Kathy Yi | SVP & Chief Financial Officer | Sell | 5,000.00 | 11.44 | 57,200.00 | 7,250.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118063265/0001209191-18-063265-index.htm |
| 2019-01-15 | Kathy Yi | SVP & Chief Financial Officer | Sell | 5,000.00 | 11.04 | 55,200.00 | 7,250.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119003926/0001209191-19-003926-index.htm |
| 2018-11-14 | H STEWART PARKER | Director | Buy | 2,000.00 | 9.00 | 18,001.60 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118058823/0001209191-18-058823-index.htm |
| 2020-05-18 | James R Meyers | Director | Buy | 2,500.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120030956/0001209191-20-030956-index.htm | ||
| 2019-06-10 | Karen L. Smith | Director | Buy | 2,500.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119036443/0001209191-19-036443-index.htm | ||
| 2020-05-18 | Robert Carey | Director | Buy | 2,500.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120030947/0001209191-20-030947-index.htm | ||
| 2020-05-18 | Saira Ramasastry | Director | Buy | 2,500.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120030961/0001209191-20-030961-index.htm | ||
| 2020-05-18 | STEPHEN GEORGE DILLY | Director | Buy | 2,500.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120030948/0001209191-20-030948-index.htm | ||
| 2020-06-04 | Stephane Boissel | EVP, Corp. Strategy | Buy | 14,907.00 | 85,023.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120034882/0001209191-20-034882-index.htm | ||
| 2019-02-25 | Sandy Macrae | President and CEO | Buy | 63,250.00 | 90,776.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919119014296/0001209191-19-014296-index.htm | ||
| 2020-02-25 | Sung Lee | EVP, Chief Financial Officer | Buy | 50,000.00 | 93,750.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919120013230/0001209191-20-013230-index.htm | ||
| 2018-09-07 | ROGER JEFFS | Director | Buy | 7,408.00 | 13.56 | 100,486.56 | 9,908.00 | https://www.sec.gov/Archives/edgar/data/1001233/000120919118050149/0001209191-18-050149-index.htm |